急性脑梗死患者重组组织型纤溶酶原激活物静脉溶栓后脑出血

被引:8
作者
郭义坤
李焰生
机构
[1] 上海交通大学医学院附属仁济医院神经内科
关键词
卒中; 脑缺血; 组织型纤溶酶原激活物; 血栓溶解疗法; 脑出血;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
摘要
重组组织型纤溶酶原激活物(recombinant tissue plasminogen activator,rtPA)静脉溶栓是急性缺血性卒中最有效的治疗手段,其最严重的并发症为有症状脑出血,文献报道其总体发生率为6%,与血管损伤和通透性增加有关。某些临床特征、影像学和实验室检查可预测脑出血并发症风险。溶栓治疗后发生脑出血并发症的患者病死率和致残率极高,预后很差。文章对溶栓后脑出血的分型、发生率、预测因素和预后进行了综述。
引用
收藏
页码:113 / 118
相关论文
共 17 条
  • [1] Factors Associated With Intracerebral Hemorrhage After Thrombolytic Therapy for Ischemic Stroke: Pooled Analysis of Placebo Data From the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials[J] . Brett Cucchiara,Scott E. Kasner,David Tanne,Steven R. Levine,Andrew Demchuk,Steven R. Messe,Lauren Sansing,Kennedy R. Lees,Patrick Lyden.Stroke . 2009 (9)
  • [2] Risk Assessment of Symptomatic Intracerebral Hemorrhage After Thrombolysis Using DWI-ASPECTS
    Singer, Oliver C.
    Kurre, Wiebke
    Humpich, Marek C.
    Lorenz, Matthias W.
    Kastrup, Andreas
    Liebeskind, David S.
    Thomalla, Goetz
    Fiehler, Jens
    Berkefeld, Joachim
    Neumann-Haefelin, Tobias
    [J]. STROKE, 2009, 40 (08) : 2743 - 2748
  • [3] The HAT Score: A simple grading scale for predicting hemorrhage after thrombolysis[J] . M Lou,A Safdar,M Mehdiratta,S Kumar,G Schlaug,L Caplan,D Searls,M Selim.Neurology . 2008 (18)
  • [4] Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: A multicenter study[J] . M Saqqur,G Tsivgoulis,C A. Molina,A M. Demchuk,M Siddiqui,J Alvarez-Sabín,K Uchino,S Calleja,A V. Alexandrov.Neurology . 2008 (17)
  • [5] Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery[J] . Kazumi Kimura,Yasuyuki Iguchi,Kensaku Shibazaki,Junya Aoki,Yuka Terasawa.Journal of the Neurological Sciences . 2008 (1)
  • [6] Timeframe for thrombolysis in acute ischaemic stroke
    Tsivgoulis, Georgios
    Alexandrov, Andrei V.
    [J]. LANCET, 2008, 372 (9646) : 1275 - 1276
  • [7] Cholesterol Measured Before Stroke Thrombolysis Is Not Associated With Tissue Plasminogen Activator–Related Hemorrhagic Transformation[J] . Joan Montaner.Stroke . 2008 (1)
  • [8] Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study[J] . Nils Wahlgren,Niaz Ahmed,Antoni Dávalos,Gary A Ford,Martin Grond,Werner Hacke,Michael G Hennerici,Markku Kaste,Sonja Kuelkens,Vincent Larrue,Kennedy R Lees,Risto O Roine,Lauri Soinne,Danilo Toni,Geert Vanhooren.The Lancet . 2007 (9558)
  • [9] Serum Cellular Fibronectin and Matrix Metalloproteinase-9 as Screening Biomarkers for the Prediction of Parenchymal Hematoma After Thrombolytic Therapy in Acute Ischemic Stroke: A Multicenter Confirmatory Study[J] . Mar Castellanos,Tomás Sobrino,Mónica Millán,María García,Juan Arenillas,Florentino Nombela,David Brea,Natalia Perez de la Ossa,Joaquín Serena,José Vivancos,José Castillo,Antoni Dávalos.Stroke . 2007 (6)
  • [10] Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator
    Alvarez-Sabin, Jose
    Huertas, Rafael
    Quintana, Manolo
    Rubiera, Marta
    Delgado, Pilar
    Ribo, Marc
    Molina, Carlos A.
    Montaner, Joan
    [J]. STROKE, 2007, 38 (03) : 1076 - 1078